# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064448
Filing Date
2025-05-06
Accepted
2025-05-06 16:07:37
Documents
85
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acet-20250331.htm iXBRL | 10-Q | 2329643
2 | EX-31.1 | acet-ex31_1.htm | EX-31.1 | 16679
3 | EX-31.2 | acet-ex31_2.htm | EX-31.2 | 16824
4 | EX-32.1 | acet-ex32_1.htm | EX-32.1 | 13351
| Complete submission text file | 0000950170-25-064448.txt |  | 9659106

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acet-20250331.xsd | EX-101.SCH | 1499735
87 | EXTRACTED XBRL INSTANCE DOCUMENT | acet-20250331_htm.xml | XML | 1588752

Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 25917256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)